VOLUME 59   1998   NUMBER 2

Brainstorms

47 How Psychiatrists Can Build New Therapies for Impotence. Stephen M. Stahl
[PDF]

Original Articles

49 Should Anxiety and Insomnia Influence Antidepressant Selection: A Randomized Comparison of Fluoxetine and Imipramine. Gregory E. Simon, John H. Heiligenstein, Louis Grothaus, Wayne Katon, and Dennis Revicki
[Abstract] [PDF]

56 Buspirone in the Management of Anxiety and Irritability in Children With Pervasive Developmental Disorders: Results of an Open-Label Study. Jan K. Buitelaar, Rutger Jan van der Gaag, and Joost van der Hoeven
[Abstract] [PDF]

60 Occurrence and Clinical Correlates of Psychiatric Comorbidity in Patients With Psychotic Disorders. Giovanni B. Cassano, Stefano Pini, Marco Saettoni, Paola Rucci, and Liliana Dell'Osso
[Abstract] [PDF]

69 The Prevalence of Acute Extrapyramidal Signs and Symptoms in Patients Treated With Clozapine, Risperidone, and Conventional Antipsychotics. Carl H. Miller, Fritz Mohr, Daniel Umbricht, Margaret Woerner, W. Wolfgang Fleischhacker, and Jeffrey A. Lieberman
[Abstract] [PDF]

76 Treatment of Premenstrual Dysphoric Disorder With Sertraline During the Luteal Phase: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial. Stephen A. Young, Peyton H. Hurt, David M. Benedek, and Robin S. Howard
[PDF]

CME Activity 88

89 Treatment Algorithm Use to Optimize Management of Symptomatic Patients With a History of Mania. Trisha Suppes, A. John Rush, Jr., Helena C. Kraemer, and Andrew Webb
[Abstract] [PDF]

Letters to the Editor

81 Seizure During Risperidone Treatment in an Elderly Woman Treated With Concomitant Medications. Hsien-Yuan Lane, Wen-Ho Chang, and James C.-Y. Chou
[PDF]

82 Valproate Monotherapy in an SRI-Intolerant OCD Patient. Gabriela Corá-Locatelli, Benjamin D. Greenberg, Juliet D. Martin, and Dennis L. Murphy
[PDF]

82 Risperidone and Allergic Reactions. Takeshi Terao, Hideki Kojima, and Akira Eto
[PDF]

83 Delirium With Manic Symptoms Induced by Diet Pills. Sushil Bagri and Giridhar Reddy
[PDF]

83 Rapid Efficacy of Olanzapine Augmentation in Nonpsychotic Bipolar Mixed States. Terence A. Ketter, Mirène E. Winsberg, Sallie G. DeGolia, Magdolna Dunai, Debbie L. Tate, and Connie M. Strong
[PDF]

85 Mania Induced by Risperidone: Dose Related? HsienYuan Lane, YuiChing Lin, and WenHo Chang
[PDF]

86 Emergence of Koro After Abrupt Cessation of Olanzapine. Rachelle H. Ramos and Cathy L. Budman
[PDF]

87 Recurrence of Lamotrigine-Associated Rash With Rechallenge. Randall D. Buzan and Steven L. Dubovsky
[PDF]

87 Problems With Switching Rapidly From One MAOI to Another. James W. Jefferson
[PDF]

Information for authors

see January 1998, pages 33-3